Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Beyond GLP-1, the market encompasses peptide cancer therapies (Oncology Peptide Therapy at 4.1% share, 11.79% CAGR), somatostatin analogues for neuroendocrine tumours, GnRH agonists/antagonists for hormone-sensitive cancers, radioligand therapy, and reproductive medicine peptides each representing strategically important niches with their own competitive dynamics
Sustained release of antibiotic from poly(2-hydroxyethyl methacrylate) to prevent blinding infections after cataract surgery
Rybelsus (semaglutide) is FDA approved for Type 2 diabetes
When should I call my healthcare provider about an injection problem
US$ 29.71
US$ 29.24
US$ 25.85
US$ 21.06
US$ 29.66
US$ 25.63
US$ 24.25
US$ 21.01
US$ 23.09
US$ 21.12
